Introduction
============

Porcine reproductive and respiratory syndrome virus (PRRSV) belongs to the genus *Arterivirus* within the family *Arteriviridae*, order *Nidovirales*, and is divided into genotype 1 (PRRSV-1) and genotype 2 (PRRSV-2; [@B33]). Both genotypes present a high degree of inter- and intra-genotype variability with different subtypes varying in virulence. Originally, more virulent isolates were discovered only in genotype 2 which were termed "highly pathogenic" (HP)-PRRSV strains, but recently highly virulent PRRSV-1 isolates were found also in subtype 3 viruses from Eastern Europe ([@B38]; [@B22]; [@B36]; [@B39]). The disease syndrome caused by PRRSV is characterized by reproductive failure in sows as well as respiratory disease in piglets and growing pigs ([@B10]). The virus has a high prevalence in intensive pig farms causing major economic losses to the swine industry worldwide, with estimated losses of up to \$664 million annually in the USA pork industry for instance ([@B20]).

PRRSV shows a restricted tropism for cells from the monocyte/macrophage lineage, with main target cells for viral replication being the alveolar and other tissue macrophages (MØ; [@B46]). It is believed that MØ-targeting by PRRSV is associated with the ability of the virus to suppress immune responses resulting in delayed innate and adaptive immune responses and secondary bacterial infections ([@B37]; [@B31]; [@B28]; [@B44]; [@B52]). Not surprisingly, interferon type I (IFN-I) responses in several monocytic cell populations including porcine alveolar MØ (PAM), monocyte derived dendritic cells (MoDC) or monocyte-derived MØ are suppressed by the virus and several viral genes, and their mechanism of action have been described ([@B1]; [@B4]; [@B25]; [@B6]; [@B34]; [@B53]). Despite this fact, in PRRSV infected pigs systemic IFN alpha (IFN-α) responses have been reported ([@B47]), which show particularly high levels during highly pathogenic (HP)-PRRSV infection ([@B15]). A possible source of this IFN-α could be from plasmacytoid DC (pDC), which are able to produce IFN-α after stimulation with PRRSV *in vitro*, although some strain-dependent differences were found ([@B3]).

The pDC are a subset of the DC family specialized in sensing nucleic acids, resulting in the production of high levels of IFN-α secretion. Typically, this is induced by triggering endosomal Toll-like receptor (TLR) 7 and TLR9 through exposure to ssRNA or DNA, respectively. These cells produce up to 1000 times more IFN-α than any other cellular type, acting as main source of systemic IFN-I at the early stage of many virus infections ([@B27]). In pigs, pDC are well described and represent 0.1--0.3% of blood leukocytes and respond to many porcine viral pathogens that control IFN-I in other cell types. It is evident that the quantity of IFN-α secreted by porcine pDC is highly variable depending on the virus studied. For example, influenza virus and transmissible gastroenteritis virus are amongst the most potent stimulators of pDC while responses induced by porcine circovirus and foot-and-mouth disease virus are rather low in comparison. In this range of IFN-α responses induced by various viruses, PRRSV can be classified as an intermediate simulator of pDC ([@B3]). This activation involves TLR7 and is not associated with pDC infection.

Here, we demonstrate that the recently emerged more virulent PRRSV strain Lena is unable to activate pDC *in vitro* while inducing high levels of IFN-α *in vivo*. We found a possible explanation for this discrepancy by demonstrating that PRRSV infected MØ are most potent at activating pDC independently of the strain employed. This activation requires cell-adhesion molecule-mediated contact between MØ and pDC, an intact cytoskeleton and sphingomyelinase activity in the infected MØ but is not caused by free PRRSV virions released from the infected MØ. Thus, pDC function as most efficient sensors of PRRSV-infected cells as described for other viruses.

Materials and Methods {#s1}
=====================

Cell Preparations
-----------------

Monocyte-derived MØ were generated from monocytes, and blood-derived pDC were enriched as previously described ([@B5]; [@B17]). Briefly, peripheral blood mononuclear cells (PBMCs) were taken from 6-weeks-old to 12-months-old specific pathogen free (SPF) Swiss Large White pigs (blood sampling approved by the cantonal ethical committee for animal experiments, license \#BE88/14) using ficoll-paque density centrifugation (1.077 g/L; Amersham Pharmacia Biotech, Dübendorf, Switzerland). Then, cells were sorted using the CD172a^+^ monoclonal antibody (mAb, clone 74-22-15A, hybridomas kindly provided by Dr. A. Saalmüller, Veterinary University of Vienna, Austria) using MACS with LS columns (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) for monocytes and LD columns (Miltenyi) for pDC enrichment. This sorting enriched pDC by a factor of 10--20 resulting in a frequency of 2--8% ([@B3]). In order to generate MØ, monocytes were seeded in 24-well culture plates at 5 × 10^5^ cells/ml in Dulbecco's modified Eagle's medium containing Glutamax (DMEM, Life Technologies, Zug, Switzerland) supplemented with 10% of heat-inactivated SPF porcine serum (produced in-house) and cultured for 3 days at 39°C and 5% CO~2~. Enriched pDC were cultured in DMEM with 10% fetal bovine serum (FBS; Biowest, Nuaillé, France) and 20 μM of β-mercaptoethanol (Invitrogen, Zug, Switzerland). MARC-145 cells (African green monkey kidney derived cells; ATCC, LGC Standards, Molsheim, France) were cultured in 24-well culture plates at 8 × 10^4^ cells/ml in DMEM with 10% of FBS at 37°C and 5% CO~2~. Exosomes released from infected MØ were isolated with the "total exosome isolation reagent" (Life Technologies) according to the manufacturer instructions.

Viruses
-------

The following PRRSV strains were employed: LVP23, representing Lelystad virus adapted to grow in MARC-145 cells; Lena strain, representing a subtype 3 PRRSV-1 (kindly provided by Prof. Hans Nauwynk, Ghent University, Belgium); VR-2332 (ATCC) a prototype PRRSV-2 strain ([@B7]), and RVB-581 (kindly obtained from Prof. Martin Beer, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Germany) representing a HP-PRRSV field strain isolated in China ([@B48]). All PRRSV strains used in this study were propagated in MØ cultures as described ([@B14]). Virus titers were determined in MØ using the immunoperoxidase monolayer assay (IPMA) with the anti-nucleocapsid (N) mAb SDOW17-A (Rural Technology, Inc., Brookings, SD, USA). Titers were calculated and expressed as 50% tissue culture infective dose per ml (TCID~50~/ml).

PRRSV Lena-Infection of Pigs
----------------------------

With the purpose of producing sera from pigs infected with a prototype genotype 1 subtype 3 virus for the implementation of diagnostic ELISAs and RT-qPCR for detection of PRRSV-1 subtype 3 infection, three 6-weeks-old SPF pigs were inoculated intranasally with 5 ml of DMEM containing 5 × 10^5^ TCID~50~ of PRRSV Lena. The experiment was performed at the IVI facilities and approved by the cantonal ethical committee for animal experiments (license \#BE119/13). One animal was euthanized at 8 days post-infection (dpi) and the other two were kept for 52 dpi for long-term antiserum production. We took advantage of these sera for determining the time course of IFN-α production following PRRSV Lena infection.

Stimulation of pDC
------------------

For pDC stimulation by PRRSV virions, 4 × 10^5^ enriched pDC/well of a 96-well plate were cultured in 200 μl and stimulated with various PRRSV strains at a multiplicity of infection (MOI) 0.1 TCID~50~/cell for 24 h at 39°C in 5% of CO~2~ atmosphere.

For pDC stimulation with infected cells, MØ and MARC-145 cells were first infected at an MOI of 0.1 TCID~50~/ml, or treated with mock cell extract as negative control. After virus adsorption for 1.5 h the cells were washed three times with warm PBS to remove the inoculum. Then, enriched pDC were added to the infected cells at 1 × 10^6^ cells/ml. Physical separation of infected MØ from pDC employed 24-well plates with trans-well inserts with 1 μm diameter pores (Corning, Sigma-Aldrich, Buchs, Switzerland and Becton Dickinson, Basel, Switzerland), into which 10^6^ enriched pDC were added in 100 μl medium.

As positive control for pDC stimulation, we used the TLR-9 ligand CpG oligodinucleotide D32 (10 μg/ml, Biosource, Int., Camarillo, CA, USA) or the TLR7 ligand Gardiquimod (10 μM, Invivogen, San Diego, CA, USA). IFN-α in supernatants was determined using ELISA as previously described ([@B16]).

Inhibition of pDC Sensing
-------------------------

In order to disrupt the cytoskeleton of freshly infected MØ, the cells were treated during 2 h with Nocodazole (10 μM; Sigma-Aldrich; interferes with microtubule polymerization) or Latrunculin B (3 μM; Sigma-Aldrich, Chemie GmbH, Buchs, Switzerland; inhibitor of actin polymerization), and then washed three times with warm medium before co-culture with enriched pDC. For the study of cell membrane functions GW4869 (Sigma-Aldrich) was used. This is a non-competitive neutral-sphingomyelinase (N-SMase) inhibitor preventing ceramide synthesis, which is widely used to block exosome generation ([@B23]). In order to test the effect of GW4869 on infected MØ, the cells were treated with culture medium containing 5, 10 or 20 μM GW4869. Appropriate dimethyl sulfoxide (DMSO, Sigma-Aldrich) controls ranging from 0.1 to 0.4% v/v were used. In order to evaluate integrin interaction between PRRSV-infected MØ and pDC, anti-CD11a mAb (clone MUC76A, Monoclonal Antibody Center, Washington State University, Pullman, WA, USA) was added to the co-culture at 10 or 30 μg/ml. In other experiments, anti-CD11a was used at 30 μg/ml in the medium of pDC in presence of exosome fractions from Lena-infected MØ.

Flow Cytometry
--------------

For detection of the PRRSV N protein, MØ were harvested and fixed with 4% (w/v) paraformaldehyde (PFA) during 10 min at room temperature. The cells were then washed and permeabilized with 0.3% (w/v) Saponin in PBS in presence of SDOW17-A mAb (Rural Technologies, Inc., Brookings, SD, USA) for 15 min on ice, followed by incubation with an anti-mouse Alexa 488 fluochrome conjugate for 15 min (Life Technologies).

IFN-α-producing cells in PRRSV-infected MØ-pDC co-cultures were identified by intracellular IFN-α immunostaining after 12 h of culture. Brefeldin A (eBioscience, Austria) was added during the last 4 h. As control, enriched pDC were stimulated with CpG D32. The cells were stained for CD4 (mAb PT90A, VMRD Inc.) and CD172a (mAb 74-22-15a), fixed, and permeabilized in presence of anti-IFN-α mAb F17 (0.3 μg/ml; R&D Systems) as previously described ([@B3]). The acquisition was performed on a FACSCanto (Becton Dickinson). For analysis, dead cells were excluded by electronic gating in forward/side scatter plots, followed by doublet discrimination. The pDC population was defined as CD172^low^CD4^high^, and MØ as CD172^high^CD4^neg^ ([@B41]). Flowjo V.9.1 analysis software (Treestars, Inc., Ashland, OR, USA) was used.

RNA Extraction and Reverse Transcription Quantitative Polymerase Chain Reaction
-------------------------------------------------------------------------------

Total RNA from serum of Lena-infected pigs and PRRSV-infected MØ supernatant was extracted using the Nucleospin RNA II kit (Macherey-Nagel AG, Oensingen, Switzerland) following the manufacturer's instructions, including DNase treatment and DNase inactivation steps. PRRSV reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed as previously described ([@B48]). Briefly, RNA was added as template to the SuperScript III Platinium One-Step qRT-PCR System (Life Technologies) with ROX reference dye following the manufacturer's instructions. The amplification was carried out using the 7500 Real-time PCR system (Applied Biosystem, Rotkreuz, Switzerland). The thermal cycling setup was 30 min at 50°C for the RT step, followed by the qPCR steps which included 2 min at 95°C of enzyme activation step, and 50 cycles of denaturation at 95°C for 15 s, annealing at 60°C for 30 s and extension at 72°C for 30 s. The quantification cycle (Cq) was determined and the results represented as the total number of cycles minus the Cq for each sample.

Confocal Microscopy
-------------------

MØ were differentiated in Lab-Tek II (Nunc; Milian, Geneva, Switzerland) at a density of 2.5 × 10^5^ cells/well in medium and infected as described above. 5 × 10^5^ enriched pDC were added and co-cultured with the MØ during 16 h at 39°C in 5% CO~2~ atmosphere. After incubation cells were washed with PBS and incubated with primary mAb against CD4 (clone PT90A; Monoclonal Antibody Center) for pDC labeling during 20 min at room temperature. After wash with cold PBS, the MØ cell membrane was stained with wheat germ agglutinin conjugated with Alexa Fluor633 (GWA-AF633; Life Technologies) during 1.5 min on ice, and washed twice with cold PBS. Then, the cells were fixed with 4% (w/v) PFA and permeabilized with 0.3% saponin (w/v) in PBS and PRRSV N protein was immunolabeled with SDOW17-A mAb during 20 min on ice. After a wash step with 0.1% (w/v) saponin in PBS, cells were incubated with secondary conjugated antibodies (Alexa488 or Alexa546; Life Technologies, Zug, Switzerland) in 0.3% saponin (w/v) in PBS for 20 min on ice. After washing with 0.1% (w/v) saponin in PBS, slides were mounted in Mowiol (Sigma-Aldrich). For confocal microscopy analysis a Leica TCS-SL confocal microscope and software (Leica Microsystem AG, Glattbrugg, Switzerland) were used. The image acquisitions were performed with the 63× oil-immersion objective; in order to give high-resolution images, the acquiring setting was performed with optimized voxel size and automatic threshold. The images were analyzed with Imaris 8.0.2 software (Bitplane AG, Zurich, Switzerland). To avoid false-positive emissions, different settings were applied including background subtraction, threshold applications, gamma correction, and maxima. The MØ and pDC surfaces were defined applying the surface module of the Imaris 8.0.2 software to GWA-AF633 and CD4-AF488 labeling, respectively. pDC tightly adhering to MØ were quantified after 16 h of co-culture. To this end, non-adherent cells were removed by washing the cultures twice with warm medium, and 20 different non-overlapping fields were counted in triplicate wells using confocal microscopy.

Statistics
----------

All experiments were done in triplicates and at least three times with cells from different blood donors. Figures and data collection analysis were done using GraphPad Prism 6 Software (GraphPad Software, Inc., San Diego, CA, USA). *P*-values were calculated by unpaired *t*-test, differences between groups were assessed by the Kruskas--Wallis analysis, and for individual differences the Mann--Whitney-*U*-test with Bonferroni correction as *post hoc* was employed. *P*-values lower than 0.05 were considered significant.

Results
=======

PRRSV Strain Lena Induces IFN-α in Pigs But Not in pDC Cultures Stimulated with Virions
---------------------------------------------------------------------------------------

Considering that systemic IFN-α was observed following experimental infection with PRRSV ([@B26]), we analyzed sera collected during the first week of infection of pigs with the PRRSV Lena strain for IFN-α by ELISA (**Figure [1A](#F1){ref-type="fig"}**). In all animals a rapid and robust IFN-α production peaking at 2 dpi, with values ranging from 163 to 205 U/ml, was observed. Between 5 and 6 dpi the sera became negative, while viral RNA was detectable up to 28 dpi (**Figure [1B](#F1){ref-type="fig"}**). Both, type 1 and type 2 PRRSV isolates are able to induce IFN-α responses in pDC, as we have described previously ([@B3]). The pDC may therefore represent an *in vivo* source for the systemic IFN-α response shown in **Figure [1A](#F1){ref-type="fig"}**. For this reason, we stimulated enriched pDC *in vitro* by PRRSV strains known to activated pDC including LVP-23, VR-2332, and RVB-581 as well as by the Lena strain. As shown in **Figure [1C](#F1){ref-type="fig"}**, all PRRSV strains promoted IFN-α secretion by pDC with the exception of Lena. Therefore, alternative pathways of IFN-α induction are required to explain the *in vivo* responses.

![**The porcine reproductive and respiratory syndrome virus (PRRSV) Lena strain induces IFN-α in infected animals but cannot directly activate pDC *in vitro*.** **(A)** Serum IFN-α responses of pigs infected oronasally with PRRSV Lena (5 × 10^5^ TCID~50~ per animal), as determined by ELISA. **(B)** Viral RNA loads in the serum. The data was obtained using RT-qPCR for PRRSV ORF7 and is represented as the total number of cycles minus the quantification cycle (Cq)-value. **(C)** Comparative analysis of IFN-α production by enriched pDC in response to PRRSV-1 (LVP-23 and Lena) and PRRSV-2 strains (VR-2332 and RVB-581) after stimulation with a MOI of 0.1 TCID~50~/cell. CpG D32 was included as control. The supernatants were harvested after 20 h of incubation and IFN-α was quantified by ELISA. The data represent the mean IFN-α (U/ml) of triplicate cultures, with error bars representing the standard deviation. These results are representative of at least three independent experiments.](fmicb-07-00771-g001){#F1}

PRRSV-Infected MØ Are Strong Activators of IFN-α Production by pDC in Co-culture
--------------------------------------------------------------------------------

With classical swine fever virus we have previously demonstrated that infected cells are much more potent at inducing IFN-α secretion by pDC when compared with direct stimulation by virions ([@B35]). We therefore tested the ability of PRRSV-infected cells to activate pDC. RVB-581-infected MARC-145 co-cultured with pDC resulted in IFN-α responses, but there was no difference in level of IFN-α production between direct pDC stimulation with virions and pDC stimulation with PRRSV-infected MARC-145 cells (**Figure [2A](#F2){ref-type="fig"}**). This contrasted with PRRSV-infected MØ which stimulated at least 3.7 more IFN-α secretion when co-cultured with pDC as compared to direct stimulation by the same PRRSV strain (**Figure [2B](#F2){ref-type="fig"}**). Importantly, with this co-culture model the Lena strain induced high levels of IFN-α, although this strain was not able to activate pDC directly.

![**Porcine reproductive and respiratory syndrome virus-infected MØ are strong inducers of IFN-α production by pDC.** **(A)** RVB-581-infected MARC-145 cells do not induce a stronger IFN-α secretion by pDC compared with the free viral particles effect on enriched pDC alone. MARC-145 cells were infected with RVB-581 for 90 min, washed and then co-cultured with enriched pDC. Stimulation of pDC by PRRSV virions (MOI 0.1 TCID~50~/cell) was used as control. **(B)** PRRSV-infected MØ are more potent activators of pDC as compared to virions ("alone"). Infection of cells was performed as in **(A)** using four different strains. **(C)** Stimulation of pDC by infected MØ but not by virions requires live virus. pDC were stimulated either with virions ("alone," live or inactivated \[UV\]) or with infected MØ ("MØ") as described in **(A)**. **(D)** pDC cultured in inserts of trans-well plates were either stimulated with virions ("alone"), by contact with infected MØ ("MØ") or were physically separated from the infected MØ ("MØ tw"). CpG D32 was used as a control for strong pDC activation. All data are the result of experiments performed in triplicate with 20 h of stimulation, with error bars representing the standard deviation. The figures are representative of three **(A,B)** and two **(C,D)** different experiments.](fmicb-07-00771-g002){#F2}

We have reported previously that UV-inactivated PRRSV is able to induce IFN-α secretion by direct stimulation of pDC ([@B3]). Accordingly, UV-inactivated RVB-581 induced IFN-α using direct pDC stimulation. With the Lena strain, IFN-α induction was neither found in pDC infected with live nor with UV-inactivated virus (**Figure [2C](#F2){ref-type="fig"}**). In the co-culture setup, MØ treated with UV-inactivated virus did not induce IFN-α secretion in pDC, as opposed to MØ treated with live virus (**Figure [2C](#F2){ref-type="fig"}**). These results suggest that viral replication is required for pDC activation by infected MØ.

Based on previous work demonstrating that cell-to-cell contact is necessary for pDC sensing of infected cells ([@B35]), we co-cultured pDC with PRRSV-infected MØ in trans-well culture dishes with 1 μm pore size. Our data show that PRRSV-infected MØ in direct contact with pDC promote a strong IFN-α secretion, while no response was found when pDC were physically separated from the MØ during the 24 h of co-culture (**Figure [2D](#F2){ref-type="fig"}**). It is important to note that pDC responses induced by a CpG control were similar if pDC where in the insert or in direct contact with MØ in the bottom of the well.

During Co-Culture with PRRSV-Infected MØ Only pDC Produce IFN-α
---------------------------------------------------------------

To determine the cellular source of IFN-α and identify the frequency of IFN-α producing cells, enriched pDC were co-cultured with PRRSV-infected MØ for 20 h and stained for CD4, CD172a and intracellular IFN-α. Dependent on the experiment, approximately 20--30% of pDC (CD172a^low^CD4^+^ cells) were positive for IFN-α staining, whereas MØ remained negative (**Figures [3A--C](#F3){ref-type="fig"}**). The frequency of IFN-α^+^ pDC was higher after stimulation with CpG relating to the higher levels of secreted IFN-α in such cultures, when compared to pDC stimulated with PRRSV-infected MØ (**Figures [3A,D](#F3){ref-type="fig"}**).

![**IFN-α production is restricted to pDC during co-culture with PRRSV-infected MØ.** MØ were infected with PRRSV RVB-581 for 90 min, washed and then co-cultured with enriched pDC. Mock-treated MØ and CpG D32 stimulation were included as negative and positive controls, respectively. **(A)** Intracellular IFN-α staining of pDC (gated as CD172a^low^CD4^+^ cells) after CpG stimulation or co-culture with PRRSV-infected MØ. **(B)** Intracellular IFN-α staining of MØ (CD172a^+^CD4^-^ cells), harvested from the same co-culture as in **(A)**. **(C)** Boxplots made from nine replicates collected from three independent experiments showing the percentage of IFN-α expressing cells after stimulation as described in **(A,B)**. **(D)** IFN-α levels in supernatants collected from the experiments shown in **(A--C)**.](fmicb-07-00771-g003){#F3}

Intact Cytoskeleton and Sphingomyelinase in MØ Are Required for PRRSV-Mediated pDC Stimulation
----------------------------------------------------------------------------------------------

In order to investigate the pathways involved in communication between infected MØ and pDC, we first evaluated the role of the MØ cytoskeleton using inhibitors. To this end, MØ were infected with PRRSV for 90 min, washed and treated with nocodazole or latrunculin B for 2 h. After washing off the inhibitors, pDC were added in co-culture. Latrunculin B reduced pDC activation in terms of IFN-α production by fivefold, while no effect was found with nocodazole (**Figure [4A](#F4){ref-type="fig"}**). Importantly, in identical co-culture conditions in which the virus was replaced by CpG, latranculin B had no effect (**Figure [4A](#F4){ref-type="fig"}**). Furthermore, we demonstrated that the chemical compounds did not affect the viral replication. No major differences of PRRSV titres in supernatants from DMSO-treated (10^3.66^ TCID~50~/ml) and chemical-treated cells (10^3.5^ and 10^3.83^ TCID~50~/ml for nocodazole and latrunculin, respectively) were found.

![**Role of cytoskeleton and membrane ceramide in pDC activation by PRRSV-infected MØ.** **(A)** MØ were infected with PRRSV RVB-581 for 90 min, washed and then treated with the cytoskeleton inhibitors nocodazole (10 μM; interferes with microtubule polymerization) or latrunculin (3 μM; inhibitor of actin polymerization) or DMSO as control for 2 h at 39°C. After three washes, MØ were co-cultured with pDC. Control wells were stimulated with CpG D32. DMSO controls showed an increase in IFN-α secretion by pDC stimulated with CpG D32. **(B)** MØ were infected with PRRSV Lena for 90 min, washed and then co-cultured with pDC. Then DMSO controls or different concentrations of GW4869 (inhibitor N-SMase) at 5, 10, and 20 μM were added to the co-cultures. Mock-treated MØ and CpG D32 stimulation were included as controls. N-SMases are important in the metabolism of sphingomyelin and required to produce cell membrane ceramide and phosphocholine, which are important during intercellular interactions. For **(A,B)**, the IFN-α production was measured after 20 h of incubation in co-culture. The data represent mean values of three replicates with standard deviation, and represent three **(A)** and two **(B)** independent experiments. Different letters on top of the bars indicate significant difference based on the Mann--Whitney test (*P* \< 0.05), whereas bars sharing same letters indicate no significant differences.](fmicb-07-00771-g004){#F4}

Next we investigated a potential role of cell membrane ceramide which is required for exosome release. To this end, PRRSV-infected MØ were co-cultured with pDC in presence of GW4869, a N-SMase inhibitor preventing ceramide synthesis. We observed a GW4869-dose dependent effect on pDC activation by PRRSV-infected MØ, with up to 50% reduction of IFN-α responses at 20 μM (**Figure [4B](#F4){ref-type="fig"}**). As GW4869 was present during the whole co-culture incubation, further investigations were carried out to evaluate negative effects on pDC functions and viral replication in MØ. To this end, pDC were stimulated with the TLR9 or TLR7 ligands CpG or Gardiquimod, respectively, in presence of GW4869 at different concentrations. The pDC functions were not significantly impaired by the N-SMase inhibitor (**Supplementary Figures [S1A,B](#SM1){ref-type="supplementary-material"}**). Also no effect on PRRSV infection and replication in MØ were detected. GW4869 did not affect PRRSV infection of MØ, when present only during virus adsorption (**Supplementary Figure [S1C](#SM1){ref-type="supplementary-material"}**) or after adsorption (**Supplementary Figure [S1D](#SM1){ref-type="supplementary-material"}**). Furthermore, the drug affected neither the virus titer nor viral RNA in supernatants of PRRSV-infected MØ (**Supplementary Figures [S1E,F](#SM1){ref-type="supplementary-material"}**).

Evidence for a Role of Exosomes in pDC Stimulation by PRRSV-Infected MØ
-----------------------------------------------------------------------

As GW4869 has been described as inhibitor of exosome release ([@B23]), we investigated if exosome fractions from the supernatant of PRRSV-infected MØ can stimulate pDC and if this is inhibited by GW4869. As shown in **Figure [5A](#F5){ref-type="fig"}**, such exosomes preparations induce IFN-α in pDC, which is inhibited when the MØ are treated with GW4869. Since the exosome preparations also contained live PRRSV, we compared the levels of pDC activation by exosome preparations of RVB-581- and Lena-infected MØ with virion-induced pDC activation by the same viruses (**Figure [5B](#F5){ref-type="fig"}**). The results show that the exosome fraction of Lena-infected cells but not Lena virions themselves are able to activate pDC.

![**pDC stimulation by PRRSV-infected MØ is dependent on integrin-mediated cell contact.** **(A)** Stimulation of pDC by MØ-derived exosomes. MØ were infected with PRRSV Lena for 90 min followed by wash steps and addition of fresh medium. After 18 h of culture, exosome fractions were isolated and used to stimulate enriched pDC during 20 h at 39°C. The N-SMase inhibitor GW4869 was added at 10 μM, DMSO alone was added at 0.2% (v/v) or the cells were left untreated. **(B)** Stimulation of pDC by infected MØ is superior to exosome stimulation. pDC were stimulated with PRRSV (Lena or RVB-581) virions at MOI 0.1 TCID~50~/ml ("alone"), with PRRSV-infected (Lena or RVB-581) MØ, with exosome fractions isolated from supernatant of PRRSV-infected (Lena or RVB-581) MØ; CpG D32 was included as control of pDC activation. **(C)** pDC stimulation by infected MØ involves ITGAL (CD11a). pDC were stimulated with mock-treated MØ, with Lena virions at MOI 0.1 TCID~50~/ml ("alone") and with Lena-infected MØ. Anti-CD11a mAb was added to the co-cultures at 10 or 30 μg/ml as indicated. CpG D32 was included as control for pDC activation. **(D)** Effect of anti-CD11a on pDC stimulation by infected MØ or exosomes. pDC were stimulated with mock-treated MØ, with Lena virions at MOI 0.1 TCID~50~/ml ("alone"), with Lena-infected MØ or with the exosome fraction isolated from Lena-infected MØ. Anti-CD11a mAb was added to the co-culture and to the exosome fraction stimulation at 30 μg/ml. CpG D32 was included as control for pDC activation. Experiments were done in triplicates, and represent three **(A,B)** or two **(C,D)** different experiments. Different letters on top of the bars indicate significant difference based on the Mann--Whitney test (*P* \< 0.05), whereas bars sharing same letters indicate no significant differences.](fmicb-07-00771-g005){#F5}

Integrins Are Involved in Sensing of Infected MØ by pDC
-------------------------------------------------------

The above results of **Figure [5B](#F5){ref-type="fig"}** demonstrate that co-culture of pDC with infected MØ is much more efficient than stimulation by exosomes in terms of activating pDC. This is also supported by the observation that no IFN-α is induced when MØ are physically separated using trans-well culture dishes (**Figure [2D](#F2){ref-type="fig"}**). We therefore hypothesized that tight contact between the two cell types is required. In order to elaborate on this, we tested the effect of antibodies against the integrin α chain (ITGAL, LFA-1, or CD11a), which plays a central role in leukocyte intercellular adhesion. In fact, when PRRSV-infected MØ were co-cultured with pDC in presence of anti-CD11a mAb a dose-dependent impairment of IFN-α release from pDC was observed (**Figure [5C](#F5){ref-type="fig"}**). ITGAL blocking not only potently impaired pDC stimulation by PRRSV-infected MØ, but also had a statistically significant effect on stimulation of pDC by exosomes, although the levels of IFN-α were much lower (**Figure [5D](#F5){ref-type="fig"}**). These results indicate that ITGAL-mediated intercellular adhesion is required for efficient sensing of PRRSV-infected MØ.

pDC Are in Intimate Contact with PRRSV-Infected MØ during the Co-culture
------------------------------------------------------------------------

In order to visualize this intercellular interaction, PRRSV-infected MØ were co-cultured with pDC, and after 16 h of incubation, cell membranes of MØ and pDC as well as PRRSV N protein were fluorochrome labeled. These experiments showed that pDC and infected MØ get in close and tight contact during the co-culture. We observed a polarization of CD4 at the area of contact between the two cell membranes (**Figure [6A](#F6){ref-type="fig"}**). In cells with tight contact, we also found that PRRSV N protein appears to be directed toward pDC (**Figure [6B](#F6){ref-type="fig"}**). The Imaris software Surface Module served to create 3D images confirming the above descriptions and demonstrating a MØ "embracing" a pDC (**Figures [6C,D](#F6){ref-type="fig"}**). It is important to note that no PRRSV N protein was detected inside pDC. The frequency of MØ in tight contact with pDC, such as shown in **Figure [6A](#F6){ref-type="fig"}**, was found to be 1.3% of all counted MØ in a given field, when analyzed at 16 h after initiation of the co-cultures. The maximum theoretical value for such interactions was calculated to be around 10% as the ratio of pDC to MØ was 1:10 in the co-cultures. Such interactions were also found in pDC and MØ in uninfected cultures at a similar frequency.

![**Porcine reproductive and respiratory syndrome virus-infected MØ are in tight contact with pDC during co-culture.** MØ were infected with PRRSV Lena for 90 min followed by wash steps and then co-cultured with pDC during another 16 h. Then MØ cell membrane was labeled with GWA-AF633 (turquoise in **A**,**B**; brown in **C,D**), pDC surfaces were labeled with CD4-AF488 (green), and PRRSV N protein (red) was stained with SDOW17-A-AF546. 3D scans were acquired using confocal microscopy. **(A,B)** Two different types of the cell-to-cell contact were observed. All micrographs are 3D Blend images with threshold subtraction and gamma correction set as in mock-treated MØ. The images were acquired with zoom together with optimum resolution format to provide the best voxel size for each employed fluorochrome. **(C**,**D)** 3D images were created using the surface module of the Imaris software applied on the labeling of GWA-AF633 and CD4-AF488 for the MØ and the pDC surfaces, respectively.](fmicb-07-00771-g006){#F6}

Discussion
==========

Porcine reproductive and respiratory syndrome virus is a very weak inducer of IFN-I responses following infection of PAM, MoDC or MØ *in vitro* ([@B25]; [@B53]; [@B14]). In pDC, however, the two PRRSV genotypes are able to induce robust IFN-α responses by virion-mediated stimulation of the TLR7 pathway ([@B3]). In the present study, we found that the PRRSV-1 subtype 3 strain Lena is an exception in not being able to activate pDC directly. We currently have no explanation for this biological difference of Lena to other PRRSV strains. Considering that PRRSV does not need to replicate to activate pDC, the lack of stimulation is unlikely to be caused by inhibitory non-structural proteins of the virus. Future studies should address a possible role for the envelope glycoproteins of Lena, as this strain has been shown to differ in tropism when compared to other PRRSV-1 strains ([@B13]). It is possible that these differences result in a reduced ability of pDC to endocytose the virus for stimulation of TLR7 or alternatively that surface glycoproteins of the Lena strain have inhibitory activity on pDC.

Despite this lack of pDC activation, similar to other PRRSV strains, a short but high-level systemic IFN-α response during the first week of infection was observed in pigs infected with the Lena strain. Our *in vitro* studies, demonstrating that PRRSV-infected MØ are far more efficient at stimulating pDC than virions, resulting in almost maximum IFN-α found with this cell type, represent a possible explanation for this apparent discrepancy.

These findings relate to previous reports with other viruses including human immunodeficiency virus, hepatitis C virus (HCV), Venezuelan equine encephalitis virus, classical swine fever virus, foot-and-mouth disease virus and Dengue virus, demonstrating that virus-infected cells are often more potent activators of pDC responses, as compared to free viral particles ([@B30]; [@B43]; [@B35]; [@B54]; [@B9]; [@B12]). This increasing number of reports and the sticking efficiency of this process support an *in vivo* relevance for this mode of antiviral innate response.

As described for other viruses this pathway of pDC activation is dependent on cell-to-cell contact, in which the integrity of actin microfilaments in the cytoskeleton of the MØ are important. In addition, active N-SMase was required in the infected cells, indicating a role for membrane ceramide. In order to inhibit N-SMase, we employed GW4869 which was used as exosome release inhibitor ([@B23]), pointing on a possible role for such microvesicles, as has been described for HCV and Lymphocytic Choriomeningitis Virus ([@B11]; [@B50]). Such exosomes have been postulated to transfer viral RNA to the TLR7 compartment of pDC ([@B11]; [@B50]). Nevertheless, while we were able to demonstrate that in contrast to Lena virions, the exosome-rich fraction of Lena-infected MØ is able to stimulate pDC, our results also show that pDC activation by PRRSV-infected cells is much stronger than activation by the exosome fraction. In addition, GW4869 only partially inhibited pDC activation by PRRSV-infected cells, questioning whether exosomes containing viral RNA are the main inducers of pDC responses in our model. In support of this, blocking the integrin ITGAL (CD11a) abrogated the ability of pDC to sense PRRSV-infected cells, while it had no effect on pDC activation mediated by the exosome-fraction. ITGAL plays a central role in leucocyte intercellular interactions through binding to intercellular adhesion molecules 1-3 (ICAM; [@B19]; [@B32]; [@B49]; [@B18]). This interaction has various functions in the immune response, one of them being the interaction between T cells and antigen-presenting cells, which also requires intimate intercellular contact for the formation of the "immunological synapse" ([@B21]; [@B29]). It has also been described that NK cells promote IFN-I responses through direct contact with pDC, with ITGAL (LFA-1) being involved ([@B18]). During our confocal microscopy analysis, we found numerous strikingly tight interactions between infected MØ and pDC. We speculate that such interactions could be involved during the transfer of viral RNA to the TLR7 compartment of pDC. In lymphoid tissues from PRRSV-infected pigs, cells expressing IFN-α in close proximity to PRRSV-infected cells have been described ([@B2]), which support this idea. Clearly, future studies are required to investigate the role and the biology of the interaction of pDC with infected cells.

Conclusion
==========

While PRRSV clearly suppresses IFN-I induction in its target cells used for replication, our data suggest that during the interaction with pDC the host can make considerable quantities of IFN-α. This and the robust systemic IFN-α response are questioning the concept of PRRSV as a virus, which is not well sensed by the innate immune system ([@B1]; [@B24]; [@B8]). Having said that, the immunology of PRRSV is quite complex and the virus clearly has established many mechanisms to prevent efficient immune responses resulting in a slow resolution of the infection ([@B51]; [@B6]; [@B34]). More generally, the ability of pDC to sense efficiently virus-infected cells and not only free virions offers the innate immune system a possibility to react to viruses before they are released from the infected cells. In addition to the antiviral activity, this early boost of the IFN system will alert the immune system and initiate the induction of adaptive immune responses. On the other hand, IFN type I responses also represent a double-edge sword as they can be associated with severe immunopathology such as observed during classical swine fever virus infection ([@B42]) or many other viral diseases ([@B45]). Deleterious effects are particularly observed with prolonged systemic IFN type I responses found in certain chronic virus infections ([@B40]; [@B45]). Of particular relevance for PRRS, could be a possible association between IFN type I responses in the lung and secondary bacterial infections as reported for other viruses ([@B45]). Clearly, future *in vivo* studies are required to address the role of pDC and IFN-α in the immune response against PRRSV.
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**FIGURE S1 \| GW4869, a non-competitive inhibitor of N-SMase neither affects TLR9 nor TLR7 signaling in pDC nor PRRSV infection and replication in MØ.** pDC were stimulated with TLR9 ligand CpG D32 **(A)** or with TLR7 ligand Gardiquimod **(B)** and treated with DMSO control at different concentrations (0.1, 0.2, and 0.4% v/v), in presence or absence of GW4869 at 5, 10, and 20 μM. These results demonstrate that IFN-α production by pDC was not affected by N-SMase inhibitor (GW4869) at any tested concentration. **(C)** MØ were infected with PRRSV Lena in the presence of GW4869 during the virus adsorption incubation time. After 90 min, the cells were washed and incubated for 16 h before PRRSV N expressing cells were quantified by flow cytometry; demonstrating that this inhibitor does not affect the virus entry into the target cells. In **(D)** GW4869 was present only after the 90 min adsorption period, which shows that GW4869 has no effect on the viral replication in MØ. **(E)** PRRSV virus titres in supernatant collected from **(C)**. **(F)** PRRSV RNA levels in supernatants of **(C)** quantified using RT-qPCR. Both **(E,F)** confirm observations previously done in **(D)**. Significant differences between conditions are indicated by asterisks based on the Mann--Whitney test (^∗^*P* \< 0.05).
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